Clinical trial
24-wk Efficacy and Safety of Flibanserin vs Pbo in Naturally Postmenopausal Women in United States
NCT00996372 is registered in ClinicalTrials.gov with Sprout Pharmaceuticals, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 24-wk Efficacy and Safety of Flibanserin vs Pbo in Naturally Postmenopausal Women in United States
- Lead sponsor
- Sprout Pharmaceuticals, Inc
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2009
- Completion date
- March 31, 2011
- Enrollment
- 949 (actual)
- Sites
- 75
Conditions
As the registry lists them; a condition with its own page is linked.